FDA Approves Generic Version of Blood Pressure Drug Plendil (Felodipine)

Quick generic drug approval bulletin for today. If you have a family member or other loved suffers from high blood pressure, the U.S. Food and Drug Administration has given Glenmark final approval for their generic version of extended release Astrazeneca’s prescription drug Plendil (felodipine) which treats high blood pressure (hypertension). According to the American Heart Association, the possible consequences of untreated high blood pressure include damage to the heart or arteries, stroke, kidney damage, vision loss, erectile dysfunction, memory loss, fluid in the lungs and angina.

Considering a thirty-day supply of brand-name Plendil is currently running about $50, generic extended-release felodipine could easily be a major savings for the families of many high blood pressure patients, so if someone in your family suffers from high blood pressure and is on Plendil, you should ask their doctor if they are an appropriate candidate for the Plendil generic counterpart.

Glenmark’sextended-release felodipine tablets will be available in strengths of 2.5 mg, 5 mg and 10 mg and are indicated for the treatment of hypertension (high blood pressure).

Does someone in your family use Plendil? Tell us about it!

Related posts:

1. Blood Pressure Drugs Cozaar and Hyzaar to Finally Go Generic
2. Generic Drug Alert: FDA Approves Generic Version of Lovenox Blood-Thinner
3. FDA Approves Generic Version of Aricept for Alzheimer’s To Be Sold Immediately
4. Huge Generic Drug News! FDA Grants Tentative Approval for Generic Version of Cholesterol Drug Crestor
5. New Generic Drug Approval: Generic Flomax for BPH